Henry Schein, Inc. (NASDAQ:HSIC) has been assigned an average recommendation of “Hold” from the twenty-one analysts that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and nine have issued a buy recommendation on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $81.20.
A number of research firms have recently issued reports on HSIC. Leerink Swann upgraded shares of Henry Schein from a “market perform” rating to an “outperform” rating and set a $75.00 target price for the company in a research note on Wednesday. BidaskClub upgraded shares of Henry Schein from a “strong sell” rating to a “sell” rating in a research note on Tuesday, March 27th. Barclays began coverage on shares of Henry Schein in a research note on Thursday, March 8th. They set an “equal weight” rating and a $71.00 target price for the company. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Tuesday, March 6th. Finally, Bank of America began coverage on shares of Henry Schein in a research note on Tuesday, February 27th. They set a “neutral” rating and a $76.00 target price for the company.
A number of large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. increased its position in Henry Schein by 0.8% during the fourth quarter. BlackRock Inc. now owns 11,752,750 shares of the company’s stock worth $821,284,000 after acquiring an additional 95,088 shares during the period. Generation Investment Management LLP increased its holdings in Henry Schein by 561.1% in the 4th quarter. Generation Investment Management LLP now owns 11,026,174 shares of the company’s stock valued at $770,509,000 after buying an additional 9,358,345 shares during the period. Mackenzie Financial Corp increased its holdings in Henry Schein by 53.0% in the 4th quarter. Mackenzie Financial Corp now owns 6,023,557 shares of the company’s stock valued at $420,926,000 after buying an additional 2,085,324 shares during the period. Janus Henderson Group PLC increased its holdings in Henry Schein by 92.1% in the 3rd quarter. Janus Henderson Group PLC now owns 2,814,636 shares of the company’s stock valued at $230,777,000 after buying an additional 1,349,333 shares during the period. Finally, Atlanta Capital Management Co. L L C increased its holdings in Henry Schein by 99.4% in the 3rd quarter. Atlanta Capital Management Co. L L C now owns 2,493,054 shares of the company’s stock valued at $204,405,000 after buying an additional 1,242,849 shares during the period. 98.54% of the stock is currently owned by institutional investors and hedge funds.
Shares of NASDAQ HSIC traded down $1.04 during mid-day trading on Wednesday, reaching $66.78. 1,281,305 shares of the company were exchanged, compared to its average volume of 1,600,655. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.76 and a current ratio of 1.45. The stock has a market cap of $10,465.02, a PE ratio of 18.55, a P/E/G ratio of 1.66 and a beta of 1.05. Henry Schein has a twelve month low of $62.56 and a twelve month high of $93.50.
Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 20th. The company reported $0.97 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.97. The company had revenue of $3.32 billion during the quarter, compared to analysts’ expectations of $3.30 billion. Henry Schein had a net margin of 3.26% and a return on equity of 19.70%. Henry Schein’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.94 EPS. analysts predict that Henry Schein will post 4.09 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This report was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/04/07/henry-schein-inc-hsic-receives-81-20-average-target-price-from-analysts.html.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.